Tevogen Bio Holdings Inc. Common Stock (TVGN) is a publicly traded Healthcare sector company. As of May 21, 2026, TVGN trades at $10.48 with a market cap of $37.19M and a P/E ratio of -1.24. TVGN moved +0.00% today. Year to date, TVGN is -41.62%; over the trailing twelve months it is -81.93%. Its 52-week range spans $4.14 to $154.50. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces TVGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tevogen Secures $3M PIPE at $8 Per Warrant, 14% Premium: Tevogen raised $3 million through a private placement issuing 375,000 prefunded warrants at $8 each, representing a 14% premium to the May 11 closing price. Proceeds will fund operations, strategic growth initiatives and general corporate purposes, with closing expected on May 13, 2026.
| Metric | Value |
|---|---|
| Price | $10.48 |
| Market Cap | $37.19M |
| P/E Ratio | -1.24 |
| EPS | $-8.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $154.50 |
| 52-Week Low | $4.14 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $-195.62K |
| Net Income | $-26.28M |
| Gross Margin | 0.00% |
1 analysts cover TVGN: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.